Autoimmune drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Product (B cell Inhibitors, T cell inhibitors, Tumor Necrosis Factor inhibitors, Interleukin inhibitors, immunosuppressant, Beta interferon, Insulin, others); Application (Grave Diseases, Rheumatoid Arthritis, Hashimotos Thyroiditis, Vitiligo, Type 1 Diabetes, Pernicious Anemia, Others)
Report Code: TIPRE00004600 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Autoimmune drugs is a condition that results in impaired function and destruction of tissue, caused by an immune reaction. During autoimmune condition abnormal antibodies are produced that attack the body's own cells and tissues.
MARKET DYNAMICS
The Autoimmune drugs market is anticipated to grow in the forecast period owing to driving factors such as rising incidence of autoimmune conditions like rheumatoid arthritis, Type I diabetes etc., growing awareness for the treatment, increasing disease prevalence due to urban lifestyle, and affordability of the treatment. Nevertheless, lack of standard treatment, safety issues and quality issues regarding the autoimmune drugs have restricted the growth of the market during the forecast period.
MARKET SCOPE
The "Global Autoimmune drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Autoimmune drugs market with detailed market segmentation by Product, Application, and geography. The global Autoimmune drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Autoimmune drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Autoimmune drugs market is segmented on the basis of Product and Application. Based on Product the market is segmented into B cell Inhibitors, T cell inhibitors, Tumor Necrosis Factor inhibitors, Interleukin inhibitors, immunosuppressant, Beta interferon, Insulin, others. Based on Application the market is segmented into Grave Diseases, Rheumatoid Arthritis, Hashimotos Thyroiditis, Vitiligo, Type 1 Diabetes, Pernicious Anemia, OthersREGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Autoimmune drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Autoimmune drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Autoimmune drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Autoimmune drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the Autoimmune drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Autoimmune drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for Autoimmune drugs in the global market. Below mentioned is the list of few companies engaged in the Autoimmune drugs market.
The report also includes the profiles of key Autoimmune drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Autoimmune drugs is a condition that results in impaired function and destruction of tissue, caused by an immune reaction. During autoimmune condition abnormal antibodies are produced that attack the body's own cells and tissues.
MARKET DYNAMICS
The Autoimmune drugs market is anticipated to grow in the forecast period owing to driving factors such as rising incidence of autoimmune conditions like rheumatoid arthritis, Type I diabetes etc., growing awareness for the treatment, increasing disease prevalence due to urban lifestyle, and affordability of the treatment. Nevertheless, lack of standard treatment, safety issues and quality issues regarding the autoimmune drugs have restricted the growth of the market during the forecast period.
MARKET SCOPE
The "Global Autoimmune drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Autoimmune drugs market with detailed market segmentation by Product, Application, and geography. The global Autoimmune drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Autoimmune drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Autoimmune drugs market is segmented on the basis of Product and Application. Based on Product the market is segmented into B cell Inhibitors, T cell inhibitors, Tumor Necrosis Factor inhibitors, Interleukin inhibitors, immunosuppressant, Beta interferon, Insulin, others. Based on Application the market is segmented into Grave Diseases, Rheumatoid Arthritis, Hashimotos Thyroiditis, Vitiligo, Type 1 Diabetes, Pernicious Anemia, OthersREGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Autoimmune drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Autoimmune drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Autoimmune drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Autoimmune drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the Autoimmune drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Autoimmune drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for Autoimmune drugs in the global market. Below mentioned is the list of few companies engaged in the Autoimmune drugs market.
The report also includes the profiles of key Autoimmune drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Active Biotech
- AstraZeneca
- GlaxoSmithKline
- Johnson & Johnson Ltd
- Lupin Limited
- Eli Lilly and Company
- Zydus
- Bristol-Myers Squibb
- AutoImmune Inc
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Autoimmune Drugs Market - By Product
1.3.2 Autoimmune Drugs Market - By Application
1.3.3 Autoimmune Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. AUTOIMMUNE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AUTOIMMUNE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. AUTOIMMUNE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. AUTOIMMUNE DRUGS - GLOBAL MARKET OVERVIEW
6.2. AUTOIMMUNE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. AUTOIMMUNE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. B CELL INHIBITORS
7.3.1. Overview
7.3.2. B cell Inhibitors Market Forecast and Analysis
7.4. T CELL INHIBITORS
7.4.1. Overview
7.4.2. T cell inhibitors Market Forecast and Analysis
7.5. TUMOR NECROSIS FACTOR INHIBITORS
7.5.1. Overview
7.5.2. Tumor Necrosis Factor inhibitors Market Forecast and Analysis
7.6. INTERLEUKIN INHIBITORS
7.6.1. Overview
7.6.2. Interleukin inhibitors Market Forecast and Analysis
7.7. IMMUNOSUPPRESSANT
7.7.1. Overview
7.7.2. immunosuppressant Market Forecast and Analysis
7.8. BETA INTERFERON
7.8.1. Overview
7.8.2. Beta interferon Market Forecast and Analysis
7.9. INSULIN
7.9.1. Overview
7.9.2. Insulin Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. others Market Forecast and Analysis
8. AUTOIMMUNE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GRAVE DISEASES
8.3.1. Overview
8.3.2. Grave Diseases Market Forecast and Analysis
8.4. RHEUMATOID ARTHRITIS
8.4.1. Overview
8.4.2. Rheumatoid Arthritis Market Forecast and Analysis
8.5. HASHIMOTOS THYROIDITIS
8.5.1. Overview
8.5.2. Hashimotos Thyroiditis Market Forecast and Analysis
8.6. VITILIGO
8.6.1. Overview
8.6.2. Vitiligo Market Forecast and Analysis
8.7. TYPE 1 DIABETES
8.7.1. Overview
8.7.2. Type 1 Diabetes Market Forecast and Analysis
8.8. PERNICIOUS ANEMIA
8.8.1. Overview
8.8.2. Pernicious Anemia Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. AUTOIMMUNE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Autoimmune Drugs Market Overview
9.1.2 North America Autoimmune Drugs Market Forecasts and Analysis
9.1.3 North America Autoimmune Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Autoimmune Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Autoimmune Drugs Market
9.1.5.1.1 United States Autoimmune Drugs Market by Product
9.1.5.1.2 United States Autoimmune Drugs Market by Application
9.1.5.2 Canada Autoimmune Drugs Market
9.1.5.2.1 Canada Autoimmune Drugs Market by Product
9.1.5.2.2 Canada Autoimmune Drugs Market by Application
9.1.5.3 Mexico Autoimmune Drugs Market
9.1.5.3.1 Mexico Autoimmune Drugs Market by Product
9.1.5.3.2 Mexico Autoimmune Drugs Market by Application
9.1.5.4 US Autoimmune Drugs Market
9.1.5.4.1 US Autoimmune Drugs Market by Product
9.1.5.4.2 US Autoimmune Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Autoimmune Drugs Market Overview
9.2.2 Europe Autoimmune Drugs Market Forecasts and Analysis
9.2.3 Europe Autoimmune Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Autoimmune Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Autoimmune Drugs Market
9.2.5.1.1 Germany Autoimmune Drugs Market by Product
9.2.5.1.2 Germany Autoimmune Drugs Market by Application
9.2.5.2 France Autoimmune Drugs Market
9.2.5.2.1 France Autoimmune Drugs Market by Product
9.2.5.2.2 France Autoimmune Drugs Market by Application
9.2.5.3 Italy Autoimmune Drugs Market
9.2.5.3.1 Italy Autoimmune Drugs Market by Product
9.2.5.3.2 Italy Autoimmune Drugs Market by Application
9.2.5.4 Spain Autoimmune Drugs Market
9.2.5.4.1 Spain Autoimmune Drugs Market by Product
9.2.5.4.2 Spain Autoimmune Drugs Market by Application
9.2.5.5 United Kingdom Autoimmune Drugs Market
9.2.5.5.1 United Kingdom Autoimmune Drugs Market by Product
9.2.5.5.2 United Kingdom Autoimmune Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Autoimmune Drugs Market Overview
9.3.2 Asia-Pacific Autoimmune Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Autoimmune Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Autoimmune Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Autoimmune Drugs Market
9.3.5.1.1 Australia Autoimmune Drugs Market by Product
9.3.5.1.2 Australia Autoimmune Drugs Market by Application
9.3.5.2 China Autoimmune Drugs Market
9.3.5.2.1 China Autoimmune Drugs Market by Product
9.3.5.2.2 China Autoimmune Drugs Market by Application
9.3.5.3 India Autoimmune Drugs Market
9.3.5.3.1 India Autoimmune Drugs Market by Product
9.3.5.3.2 India Autoimmune Drugs Market by Application
9.3.5.4 Japan Autoimmune Drugs Market
9.3.5.4.1 Japan Autoimmune Drugs Market by Product
9.3.5.4.2 Japan Autoimmune Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Autoimmune Drugs Market Overview
9.4.2 Middle East and Africa Autoimmune Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Autoimmune Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Autoimmune Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Autoimmune Drugs Market
9.4.5.1.1 South Africa Autoimmune Drugs Market by Product
9.4.5.1.2 South Africa Autoimmune Drugs Market by Application
9.4.5.2 Saudi Arabia Autoimmune Drugs Market
9.4.5.2.1 Saudi Arabia Autoimmune Drugs Market by Product
9.4.5.2.2 Saudi Arabia Autoimmune Drugs Market by Application
9.4.5.3 U.A.E Autoimmune Drugs Market
9.4.5.3.1 U.A.E Autoimmune Drugs Market by Product
9.4.5.3.2 U.A.E Autoimmune Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Autoimmune Drugs Market Overview
9.5.2 South and Central America Autoimmune Drugs Market Forecasts and Analysis
9.5.3 South and Central America Autoimmune Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Autoimmune Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Autoimmune Drugs Market
9.5.5.1.1 Brazil Autoimmune Drugs Market by Product
9.5.5.1.2 Brazil Autoimmune Drugs Market by Application
9.5.5.2 Argentina Autoimmune Drugs Market
9.5.5.2.1 Argentina Autoimmune Drugs Market by Product
9.5.5.2.2 Argentina Autoimmune Drugs Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. AUTOIMMUNE DRUGS MARKET, KEY COMPANY PROFILES
11.1. - ABBOTT LABORATORIES, ACTIVE BIOTECH, ASTRAZENECA, GLAXOSMITHKLINE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. JOHNSON AND JOHNSON LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. LUPIN LIMITED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELI LILLY AND COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ZYDUS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BRISTOL-MYERS SQUIBB
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. AUTOIMMUNE INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Autoimmune Drugs Market - By Product
1.3.2 Autoimmune Drugs Market - By Application
1.3.3 Autoimmune Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. AUTOIMMUNE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AUTOIMMUNE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. AUTOIMMUNE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. AUTOIMMUNE DRUGS - GLOBAL MARKET OVERVIEW
6.2. AUTOIMMUNE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. AUTOIMMUNE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. B CELL INHIBITORS
7.3.1. Overview
7.3.2. B cell Inhibitors Market Forecast and Analysis
7.4. T CELL INHIBITORS
7.4.1. Overview
7.4.2. T cell inhibitors Market Forecast and Analysis
7.5. TUMOR NECROSIS FACTOR INHIBITORS
7.5.1. Overview
7.5.2. Tumor Necrosis Factor inhibitors Market Forecast and Analysis
7.6. INTERLEUKIN INHIBITORS
7.6.1. Overview
7.6.2. Interleukin inhibitors Market Forecast and Analysis
7.7. IMMUNOSUPPRESSANT
7.7.1. Overview
7.7.2. immunosuppressant Market Forecast and Analysis
7.8. BETA INTERFERON
7.8.1. Overview
7.8.2. Beta interferon Market Forecast and Analysis
7.9. INSULIN
7.9.1. Overview
7.9.2. Insulin Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. others Market Forecast and Analysis
8. AUTOIMMUNE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GRAVE DISEASES
8.3.1. Overview
8.3.2. Grave Diseases Market Forecast and Analysis
8.4. RHEUMATOID ARTHRITIS
8.4.1. Overview
8.4.2. Rheumatoid Arthritis Market Forecast and Analysis
8.5. HASHIMOTOS THYROIDITIS
8.5.1. Overview
8.5.2. Hashimotos Thyroiditis Market Forecast and Analysis
8.6. VITILIGO
8.6.1. Overview
8.6.2. Vitiligo Market Forecast and Analysis
8.7. TYPE 1 DIABETES
8.7.1. Overview
8.7.2. Type 1 Diabetes Market Forecast and Analysis
8.8. PERNICIOUS ANEMIA
8.8.1. Overview
8.8.2. Pernicious Anemia Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. AUTOIMMUNE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Autoimmune Drugs Market Overview
9.1.2 North America Autoimmune Drugs Market Forecasts and Analysis
9.1.3 North America Autoimmune Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Autoimmune Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Autoimmune Drugs Market
9.1.5.1.1 United States Autoimmune Drugs Market by Product
9.1.5.1.2 United States Autoimmune Drugs Market by Application
9.1.5.2 Canada Autoimmune Drugs Market
9.1.5.2.1 Canada Autoimmune Drugs Market by Product
9.1.5.2.2 Canada Autoimmune Drugs Market by Application
9.1.5.3 Mexico Autoimmune Drugs Market
9.1.5.3.1 Mexico Autoimmune Drugs Market by Product
9.1.5.3.2 Mexico Autoimmune Drugs Market by Application
9.1.5.4 US Autoimmune Drugs Market
9.1.5.4.1 US Autoimmune Drugs Market by Product
9.1.5.4.2 US Autoimmune Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Autoimmune Drugs Market Overview
9.2.2 Europe Autoimmune Drugs Market Forecasts and Analysis
9.2.3 Europe Autoimmune Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Autoimmune Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Autoimmune Drugs Market
9.2.5.1.1 Germany Autoimmune Drugs Market by Product
9.2.5.1.2 Germany Autoimmune Drugs Market by Application
9.2.5.2 France Autoimmune Drugs Market
9.2.5.2.1 France Autoimmune Drugs Market by Product
9.2.5.2.2 France Autoimmune Drugs Market by Application
9.2.5.3 Italy Autoimmune Drugs Market
9.2.5.3.1 Italy Autoimmune Drugs Market by Product
9.2.5.3.2 Italy Autoimmune Drugs Market by Application
9.2.5.4 Spain Autoimmune Drugs Market
9.2.5.4.1 Spain Autoimmune Drugs Market by Product
9.2.5.4.2 Spain Autoimmune Drugs Market by Application
9.2.5.5 United Kingdom Autoimmune Drugs Market
9.2.5.5.1 United Kingdom Autoimmune Drugs Market by Product
9.2.5.5.2 United Kingdom Autoimmune Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Autoimmune Drugs Market Overview
9.3.2 Asia-Pacific Autoimmune Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Autoimmune Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Autoimmune Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Autoimmune Drugs Market
9.3.5.1.1 Australia Autoimmune Drugs Market by Product
9.3.5.1.2 Australia Autoimmune Drugs Market by Application
9.3.5.2 China Autoimmune Drugs Market
9.3.5.2.1 China Autoimmune Drugs Market by Product
9.3.5.2.2 China Autoimmune Drugs Market by Application
9.3.5.3 India Autoimmune Drugs Market
9.3.5.3.1 India Autoimmune Drugs Market by Product
9.3.5.3.2 India Autoimmune Drugs Market by Application
9.3.5.4 Japan Autoimmune Drugs Market
9.3.5.4.1 Japan Autoimmune Drugs Market by Product
9.3.5.4.2 Japan Autoimmune Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Autoimmune Drugs Market Overview
9.4.2 Middle East and Africa Autoimmune Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Autoimmune Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Autoimmune Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Autoimmune Drugs Market
9.4.5.1.1 South Africa Autoimmune Drugs Market by Product
9.4.5.1.2 South Africa Autoimmune Drugs Market by Application
9.4.5.2 Saudi Arabia Autoimmune Drugs Market
9.4.5.2.1 Saudi Arabia Autoimmune Drugs Market by Product
9.4.5.2.2 Saudi Arabia Autoimmune Drugs Market by Application
9.4.5.3 U.A.E Autoimmune Drugs Market
9.4.5.3.1 U.A.E Autoimmune Drugs Market by Product
9.4.5.3.2 U.A.E Autoimmune Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Autoimmune Drugs Market Overview
9.5.2 South and Central America Autoimmune Drugs Market Forecasts and Analysis
9.5.3 South and Central America Autoimmune Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Autoimmune Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Autoimmune Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Autoimmune Drugs Market
9.5.5.1.1 Brazil Autoimmune Drugs Market by Product
9.5.5.1.2 Brazil Autoimmune Drugs Market by Application
9.5.5.2 Argentina Autoimmune Drugs Market
9.5.5.2.1 Argentina Autoimmune Drugs Market by Product
9.5.5.2.2 Argentina Autoimmune Drugs Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. AUTOIMMUNE DRUGS MARKET, KEY COMPANY PROFILES
11.1. - ABBOTT LABORATORIES, ACTIVE BIOTECH, ASTRAZENECA, GLAXOSMITHKLINE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. JOHNSON AND JOHNSON LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. LUPIN LIMITED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELI LILLY AND COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ZYDUS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BRISTOL-MYERS SQUIBB
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. AUTOIMMUNE INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
- Abbott Laboratories
- Active Biotech
- AstraZeneca
- GlaxoSmithKline
- Johnson & Johnson Ltd
- Lupin Limited
- Eli Lilly and Company
- Zydus
- Bristol-Myers Squibb
- AutoImmune Inc
- Abbott Laboratories
- Active Biotech
- AstraZeneca
- GlaxoSmithKline
- Johnson & Johnson Ltd
- Lupin Limited
- Eli Lilly and Company
- Zydus
- Bristol-Myers Squibb
- AutoImmune Inc